Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2001

View Archived Issues

Licensing opportunity from NIH: biologically active FLAG epitope-tagged TGF-beta protein

Novel inhibitors of retrovirus replication available for licensing from NIH

Revised safety information for Sporanox labeling in Canada

Mechanism of action of HIV-inactivating protein cyanovirin N explored

Oritavancin rapidly kills multidrug-resistant S. pneumoniae in vitro

Safety and efficacy of dopamine agonists in treatment of restless legs syndrome

Results from studies on neuropathic pain treatments presented at AAN meeting

Rabbit studies indicate safety, efficacy of KUR-1246 in threatened premature delivery

Neurocrine Biosciences advances NBI-34060 towards phase III trials for insomnia

Successful completion of initial human trial for testosterone patch announced by 3M

Second azelaic acid-based acne product cleared for launch by FDA

UR-3216 emerges as a promising new gpIIb/IIIa antagonist for cardiovascular disorders

Oral therapy for CML developed at Novartis approved by FDA

Activation of PPARgamma associated with apoptosis in gliomas

Proteasome inhibitor PS-519 holds promise as a therapy for psoriasis

FDA approves Almirall Prodesfarma's 5-HT1B/1D agonist for treatment of migraine

Low-dose loratadine has steroid-sparing effect in Crohn's disease patients

Johnson & Johnson acquisition of Alza proceeds on schedule

KS Biomedix moves KSB-302 into phase IIb for RA

Antifungal agent produced by species of Phoma patented by Sankyo

TPO mimetics in development at GSK

Shionogi presents new series of HIV integrase inhibitors

Merger of BioChem Pharma and Shire officially closes

Inhibitors of VSMC proliferation derived from PGE reported by Taisho

Pfizer presents new glycogen phosphorylase inhibitors and potential uses

6-Azauracils from Pfizer useful as thyroid receptor ligands

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...